What is the mechanism of action of tofacitinib tablets? How does it work in the body to improve symptoms?

Tofacitinib is a selective Janus kinase (JAK) inhibitor that modulates the immune response by inhibiting the enzyme activity of the JAK family, thereby improving the symptoms of a series of immune-related diseases. JAKThe enzyme is involved in the transmission of cytokine and growth factor signals, which are critical for the regulation of the immune system. Tofacitinib helps control the activity of autoimmune diseases by inhibiting JAK1 and JAK3, reducing the production of inflammatory cytokines.

In the body, tofacitinib is mainly absorbed through oral administration and takes effect quickly after entering the bloodstream. JAKThe enzyme is usually involved in the activation and proliferation of a variety of immune cells, especially playing a key role in the pathogenesis of rheumatoid arthritis, psoriasis, ulcerative colitis and other diseases. By inhibiting JAK1 and JAK3, tofacitinib reduces the signaling of these cytokines, thereby suppressing inflammation and immune system overreaction.

Clinically, tofacitinib has been widely used to treat immune-mediated diseases such as rheumatoid arthritis, ulcerative colitis, and psoriasis. By inhibiting overactivated immune responses, tofacitinib helps reduce patients' symptoms, such as joint pain, redness, and skin inflammation. The use of tofacitinib can improve joint function and slow down the progression of the disease, especially when other traditional drug treatments are ineffective, providing patients with an effective treatment option.

In addition, tofacitinib has a unique mechanism of action. Compared with traditional immunosuppressive drugs, it not only reduces inflammation through systemic suppression of the immune system, but also achieves more precise therapeutic effects by selectively inhibiting specific JAK enzymes. This precise treatment feature allows tofacitinib to effectively control the progression of the disease and relieve symptoms while reducing side effects. Nonetheless, tofacitinib should be used with caution, especially during long-term use, and close monitoring of infection risks and blood markers is required.